Obstetrics & gynaecology

First-void morning urine not necessary for CIN2+ detection

(HealthDay)—There is no advantage in testing morning first-void urine over later samples for cervical intraepithelial neoplasia grade 2+ (CIN2+) detection using human papillomavirus (HPV) testing, according to a study published ...

Oncology & Cancer

Study 'strongly supports' extending cervical screening intervals

Screening for high risk human papillomavirus (HR-HPV) infection works well in practice and is more sensitive than cytology (smear) testing—offering greater protection against cervical cancer, confirm researchers in The ...

Oncology & Cancer

Risk of CIN3 drops with negative HPV, cytology co-tests

(HealthDay)—The five-year risks of cervical intraepithelial neoplasia grade 3 (CIN3), adenocarcinoma in situ, and cervical cancer (≥CIN3) decrease after each successive negative human papillomavirus (HPV) and cytology ...

Oncology & Cancer

Risk of noncervical anogenital cancer up with history of CIN2/3

(HealthDay)—Women with a history of cervical intraepithelial neoplasia (CIN)2 or CIN3 have increased risks of subsequent development of anal, vulvar, and vaginal cancers, according to a study published online June 29 in ...

Oncology & Cancer

Clearing cells to prevent cervical cancer

A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after ...

page 2 from 4